Cochliodone A

Cochliodone A, a bioactive compound isolated from the deep-sea fungus Chaetomium sp., exhibits both antibacterial and anticancer properties. This substance demonstrates toxicity against multiple bacterial strains, as evidenced by its minimum inhibitory concentrations (MICs) of 15.3 μg/mL for V. vulnificus, 32.7 μg/mL for V. rotiferianus, 15.9 μg/mL for S. aureus ATCC 43300, and 16.3 μg/mL for S. aureus CGMCC 1.12409. Additionally, Cochliodone A effectively inhibits several cancer cell lines, with half-maximal inhibitory concentrations (IC50s) recorded at 28.1 μM for A549, 20.7 μM for HeLa, and 23.2 μM for Hep G2 [1].